You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MEC

Showing 1 - 25 of 448
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MCI, Mild Dementia Trial (Gentle Moves)

Not yet recruiting
  • MCI
  • Mild Dementia
  • Gentle Moves
  • (no location specified)
Mar 14, 2023

Pain Management Trial in Samsun (Regional Anesthesia Techniques)

Recruiting
  • Pain Management
  • Regional Anesthesia Techniques
  • Samsun, Turkey
    Samsun University
Dec 26, 2022

Non-invasive Urine Output Management Trial in Tampa (PureWick Male External Catheter, Sage PrimoFit)

Completed
  • Non-invasive Urine Output Management
  • PureWick Male External Catheter
  • Sage PrimoFit
  • Tampa, Florida
    USF Health Center for Advanced Medical Learning and Simulation (
Jul 13, 2023

Mapping Enhanced Counseling (MEC), Active Linkage (AL) Trial in Fort Worth (Mapping Enhanced Counseling, Active Linkage)

Recruiting
  • Mapping Enhanced Counseling (MEC)
  • Active Linkage (AL)
  • Mapping Enhanced Counseling
  • Active Linkage
  • Fort Worth, Texas
    Texas Christian University
Feb 24, 2022

Chemo-induced Nausea and Vomiting Trial in Worldwide (NEPA (300mg netupitant/0.5mg palonosetron), Granisetron, 2 mg (oral) or 1

Recruiting
  • Chemotherapy-induced Nausea and Vomiting
  • NEPA (300mg netupitant/0.5mg palonosetron)
  • +2 more
  • Prague, Czechia
  • +12 more
Nov 8, 2022

Acute Myeloid Leukemia Trial in Suzhou (CAV Regimen, MEC Regimen)

Recruiting
  • Acute Myeloid Leukemia
  • CAV Regimen
  • MEC Regimen
  • Suzhou, Jiangsu, China
    The First Affliated Hospital of Soochow University
Dec 22, 2022

AML Trial in Boston (Etoposide, Cytarabine, Lenalidomide)

Active, not recruiting
Has Results
  • AML
  • Boston, Massachusetts
  • +2 more
Jan 13, 2021

Relapsed/Refractory Acute Myeloid Leukemia Trial in Worldwide (CPI-613 + High Dose Cytarabine and Mitoxantrone, High Dose

Terminated
  • Relapsed/Refractory Acute Myeloid Leukemia
  • CPI-613 + High Dose Cytarabine and Mitoxantrone
  • +3 more
  • Scottsdale, Arizona
  • +59 more
Jul 26, 2022

Malignant Pharyngo Laryngeal Tumors, Pre-malignant Pharyngo Laryngeal Tumors Trial in Villejuif, Toulouse (Confocal Micro

Completed
  • Malignant Pharyngo Laryngeal Tumors
  • Pre-malignant Pharyngo Laryngeal Tumors
  • Confocal Micro Endoscopy
  • Villejuif, Val De Marne, France
  • +1 more
Feb 17, 2021

Mapping Approaches to Prepare for Implementation Transfer, Treatment Readiness and Induction Program Trial in Fort Worth

Active, not recruiting
  • Mapping Approaches to Prepare for Implementation Transfer
  • Treatment Readiness and Induction Program
  • Mapping Enhanced Counseling (MEC)
  • Mapping Approaches to Prepare for Implementation Transfer (MAP-IT)
  • Fort Worth, Texas
    Texas Christian University
Mar 11, 2021

Recurrent Adult Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia Trial in

Recruiting
  • Recurrent Adult Acute Myeloid Leukemia
  • +2 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Dec 7, 2020

Laparoscopic Gastrectomy Trial (Ropivacaine)

Unknown status
  • Laparoscopic Gastrectomy
  • (no location specified)
Jan 29, 2020

Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation Trial in Worldwide (gilteritinib, LoDAC (Low Dose

Active, not recruiting
  • Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation
  • Beijing, China
  • +47 more
Aug 17, 2022

Myeloid Leukemias, AML, Leukemia Trial in Philadelphia (Rapamycin, Mitoxantrone, Etoposide, Cytarabine, Rapamycin + MEC)

Completed
  • Myeloid Leukemias
  • +3 more
  • Rapamycin, Mitoxantrone, Etoposide, Cytarabine
  • Rapamycin + MEC
  • Philadelphia, Pennsylvania
    University of Pennsylvania Abramson Cancer Center
Jul 10, 2019

Myeloid Malignancies Trial in Australia, United Kingdom, United States (Magrolimab, Azacitidine, Venetoclax)

Recruiting
  • Myeloid Malignancies
  • Magrolimab
  • +6 more
  • Birmingham, Alabama
  • +12 more
Apr 6, 2022

Intracranial Aneurysm, Transradial Access(TRA) Trial in Nanjing (Ropivacaine)

Recruiting
  • Intracranial Aneurysm
  • Transradial Access(TRA)
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Sep 11, 2023

Chemo Induced Nausea and Vomiting Trial in Mount Olive (Akynzeo)

Recruiting
  • Chemotherapy Induced Nausea and Vomiting
  • Mount Olive, Alabama
    Rudolph M Navari
Oct 8, 2023

Acute Myeloid Leukemia, MDS Trial in Boston (Prexasertib, Mitoxantrone, Etoposide)

Terminated
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jun 10, 2019

Respiratory Muscle Strength, Exercise Capacity, Physical

Recruiting
  • COVID-19
  • +2 more
  • observational tests
  • Kirikkale, Turkey
    Kırıkkale University
Aug 21, 2023

Mild Cognitive Impairment, Randomized Controlled Trial Trial (Cognitive stimulation, Stimulating leisure activities)

Not yet recruiting
  • Mild Cognitive Impairment
  • Randomized Controlled Trial
  • Cognitive stimulation
  • Stimulating leisure activities
  • (no location specified)
Sep 21, 2023

Acute Myeloid Leukemia With FLT3/ITD Mutation Trial (XY0206, Salvage Chemotherapy)

Not yet recruiting
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • (no location specified)
May 24, 2023

Impact of Sedation With HFNOT on tcPCO2, mitoPO2 and mitoVO2.

Recruiting
  • Sedation Complication
  • High Flow Nasal Oxygen Therapy
  • Monitoring tcPCO2 and mitoPO2
  • Rotterdam, South Holland, Netherlands
    Erasmus MC
Nov 3, 2023

Esophageal Cancer, Active Surveillance, Neoadjuvant Chemoradiotherapy Trial in Rotterdam (Active surveillance)

Active, not recruiting
  • Esophageal Cancer
  • +3 more
  • Active surveillance
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus MC, University Medical Center
Jul 11, 2023

Azole Resistance Inducing Mutations on DNA Extracted Directly

Recruiting
  • Invasive Aspergillosis
  • Aspergillus PCR
  • Rotterdam, Zuid Holland, Netherlands
    Erasmus Medical Center (EMC)
Oct 5, 2023

Chronic Hepatitis b Trial in Rotterdam (ISA104, Placebo)

Not yet recruiting
  • Chronic Hepatitis b
  • Rotterdam, Netherlands
    Erasmus MC
Apr 21, 2023